Brigham and Women’s Hospital and Oakstone Board Review

A comprehensive board review designed to update knowledge and improve practice gaps in hematology and oncology based on American Board of Internal Medicine certification requirements. Ideal for MOC.

Stay Current with this CME Board Review in Hematology and Oncology

The Brigham Board Review in Hematology and Oncology is designed to update knowledge and improve practice gaps in hematology and oncology based on American Board of Internal Medicine certification requirements. This case-based board review will help you prep for certification/recertification with an in-depth look at the clinical essentials in both specialties. You’ll learn to:

• Perform differential diagnosis of complex hematologic and oncologic disorders
• Identify and apply current therapeutic options for hematologic and oncologic disorders
• Evaluate and interpret up-to-date literature relevant to hematology and oncology
• Illustrate knowledge of pathophysiology of hematologic and oncologic disorders

Course Directors:
Edwin P. Alyea, III, MD
Associate Professor of Medicine
Harvard Medical School
Associate Director, Bone Marrow/Stem Cell Transplantation Program
Director, Oncology Hospital Medicine
Dana Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Nancy Berliner, MD
Professor of Medicine
Harvard Medical School
Chief, Division of Hematology
Department of Medicine
Brigham and Women’s Hospital

The Brigham Board Review
Distance Learning Series
Ajay K. Singh, MBBS, FRCP (UK), MBA
Senior Associate Dean for Global and Continuing Education
Director, Master in Medical Sciences in Clinical Investigation (MMSCI) Program
Harvard Medical School
Director, Office of Postgraduate Medical Education
Physician, Division of Nephrology, Department of Medicine
Brigham and Women’s Hospital

 

TOPICS

• Molecular Genetics of Cancer – Levi A. Garraway, MD, PhD

• Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD

• Infections in Cancer Patients – Joel T. Katz, MD

• Symptom Management in Patients with Cancer – Janet L. Abrahm, MD

• Communication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD

• Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD

• Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD

• Acute Leukemias – Daniel J. DeAngelo, MD, PhD

• Myelodysplastic Syndrome – David P. Steensma, MD

• Chronic Myelogenous Leukemia – Joseph H. Antin. MD

• Myeloproliferative Syndromes – Ann M. Mullally, MD

• Multiple Myeloma – Kenneth C. Anderson, MD

• Waldenstrom’s Macroglobulemia, Amyloidosis – Irene M. Ghobrial, MD

• Low Grade Lymphomas – Caron A. Jacobson, MD

• High Grade Lymphomas – Arnold S. Freedman, MD

• Hodgkin’s Lymphoma – George P. Canellos, MD

• Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD

• Head and Neck Cancer – Robert I. Haddad, MD

• Natural History, Screening, Surgery, Small Cell Lung Cancer – Bruce E. Johnson, MD

• Non Small Cell Lung Cancer – Mark Awad, MD, PhD
  

• Mesothelioma and Thymoma – Geoffrey R. Oxnard, MD

• Thyroid Cancer – Jochen Lorch, MD

• Carcinoid and Pancreatic Neuroendocrine Tumors – Matthew H. Kulke, MD

• Esophageal and Gastric Cancer – Charles S. Fuchs, MD, MPH

• Pancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD

• Anal Cancers – Robert J. Mayer, MD

• Colorectal Cancers – Robert J. Mayer, MD

• Gastrointestinal Cancer- Genetic Syndromes – Matthew Yurgelun, MD

• Germ Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy – Christopher J. Sweeney, MBBS

• Renal and Bladder Cancer – Toni K. Choueiri, MD

• Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD

• Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD

• Melanoma – F. Stephen Hodi, MD

• Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD

• Ovarian Cancer – Ursula A. Matulonis, MD

• Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD

• Neuro-oncology – David A. Reardon, MD

• Breast Cancer: Risk Factors, Genetics, Screening and Prevention – Judy E. Garber, MD, MPH

• Breast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS – Harold J. Burstein, MD, PhD

• Management for HER2-Positive and Triple Negative Breast Cancer – Eric P. Winer, MD

• Breast Cancer Survivorship – Ann H. Partridge, MD, MPH

• Hematopoiesis and Cytokines – David T. Scadden, MD

• Acquired Bone Marrow Failure – Julie A. Losman. MD

• Congenital Bone Marrow Failure – David A. Williams, MD

• Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD

• Anemia: An Overview – Ronald P. McCaffrey, MD

• Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD

• Immune Hemolytic Anemia – Richard M. Kaufman, MD

• Non-immune Hemolytic Anemia – David E. Golan, PhD, MD

• Sickle Cell Disease – Maureen M. Okam, MD, MBBS

• Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD

• Disorders of Neutrophils – Nancy Berliner, MD

• Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD

• Hemophilia – Ellis J. Neufeld, MD, PhD

• Von Willebrand Disease and Congenital Platelet Disorders – Robert I. Handin, MD

• Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD

• New Oral Anticoagulants – Jean M. Connors, MD

• Transfusion Medicine for the Clinician – Walter H. Dzik, MD

 

Learning Objectives

Upon completion of this activity, the participant will be able to:

• Apply current/recommended Hematology and Oncology guidelines in clinical practice
• Perform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders
• Identify/apply current therapeutic options for for specific Hematologic and Oncologic disorders
• Evaluate and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology
• Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
• Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations

Intended Audience

This course is designed to provide hematology/oncology fellows/trainees, hematologists, oncologists and internists with new knowledge and management strategies to enhance the care of their patients, as well prepare candidates for the ABIM subspecialty board exams in hematology or medical oncology.

Date of Original Release: June 30, 2016
Termination Date: June 30, 2019

 

HOMEPAGE: http://www.oakstone.com/the-brigham-board-review-in-hematology-and-oncology